In this talk I will discuss highlights of our nanomedicine portfolio including nanosensors for diagnosing and monitoring infectious and non-communicable diseases [1], nanomimicking approaches for virus and parasite host cell entry inhibition recently demonstrated for malaria, HSV-2 and SARS-CoV-2 [2], and high molecular weight polymer carriers for enhanced delivery of saRNA therapeutics [3]. I will present advances in Raman spectroscopy for high-throughput label-free characterization of single nanoparticles (SPARTA™) that allow us to integrally analyse a broad range bio-nanomaterials such as polymer particles, liposomes and extracellular vesicles without any modification [4]. SPARTA™ has become an integral tool for the design of nanotherapeutics, with recent examples including DOPC-containing lipid nanoparticles for nucleic acid delivery and dendrimersome-based systems for controlled delivery of antibacterial drugs, and for profiling extracellular vesicles (EVs) for detection of breast cancer through a minimally invasive liquid biopsy. I will also discuss our cell interfacing nanoneedle platforms for multiplexed intracellular biosensing at sub-cellular resolution and modulation of biological processes [5]. I will explore how these versatile technologies can be applied to transformative biomedical innovations.
[1] C. S. Wood, et al. Nature. 2019. 566: 467-474.; C. N. Loynachan, et al. Nature Nanotechnology. 2019. 14: 883–890.
[3] A. Najer, et al. ACS Central Science. 2022. DOI: 10.1021/acscentsci.1c01368.
[4] J. Penders, et al. Nature Communications. 2018, 9: 4256.
[5] C. Chiappini, et al. Nature Materials. 2015. 14: 532
The European Laboratory Research & Innovation Group
Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Get the App
Get this event information on your mobile by going to the Apple or Google Store and search for 'myEventflo'